Le Lézard
Classified in: Business
Subject: MUTUAL FUNDS

Brompton Tech Leaders Income ETF Announces Increased Distributions and Update on Special Year End Distribution


TORONTO, Jan. 24, 2022 (GLOBE NEWSWIRE) -- (TSX: TLF, TLF.U) ? Brompton Funds is pleased to announce an increase in monthly distributions for record dates from January to March 2022 for Brompton Tech Leaders Income ETF ("the Fund"):

 Ticker Amount Per Unit
Brompton Tech Leaders Income ETFTLFCdn$ 0.08333
 TLF.UUS$ 0.08333

Record Dates and Payment Dates are as follows:

Record DatePayment Date
January 31, 2022February 14, 2022
February 28, 2022March 14, 2022
March 31, 2022April 14, 2022

The new distribution rate for TLF of $1.00 per annum, or 5.2% based on the TSX mid-day price of $19.32 on January 24, 2022, represents a 25% increase from the previous level. TLF has paid 127 consecutive monthly distributions since inception on May 20, 2011 for total distributions of $7.03 per unit. TLF.U is the unhedged unit and will also enjoy a US$1.00 per unit annual distribution rate.

On December 22, 2021, the Fund announced a special year end distribution for TLF estimated to be $1.55 per unit to unitholders of record at the close of business on December 31, 2021 which were automatically reinvested in additional units. Immediately following the issuance, the units of TLF were automatically consolidated and as a result, unitholders held the same number of units after the distribution as they did before. This amount is final at $1.55 per unit.

The Fund provides investors with exposure to a portfolio of equity securities of large capitalization global Technology companies, providing the opportunity for capital appreciation, and the opportunity for enhanced distributions and higher risk-adjusted returns due to an active covered-call writing program.

Unitholders are reminded that TLF offers a distribution reinvestment plan ("DRIP") which provide unitholders with the ability to automatically reinvest distributions, commission free, and realize the benefits of compound growth. Unitholders can enroll in a DRIP program by contacting their investment advisor.

About Brompton Funds
Founded in 2000, Brompton is an experienced investment fund manager with income focused investment solutions including exchange-traded funds (ETFs) and other TSX traded investment funds. For further information, please contact your investment advisor, call Brompton's investor relations line at 416-642-6000 (toll-free at 1-866-642-6001), email [email protected] or visit our website at www.bromptongroup.com.

Annual Compound Returns1-year3-year5-year10-yearSince Inception TLFSince Inception TLF.U
Brompton Tech Leaders Income ETF ? (CAD hedged)30.4%35.3%28.2%17.8%15.9%-
Brompton Tech Leaders Income ETF ? (USD)31.0%-- -35.6%

Returns are for the periods ended December 31, 2021 and are unaudited. TLF inception date May 20, 2011. TLF.U inception date August 8, 2019. This table shows the unit's compound return for each period indicated.

Commissions, trailing commissions, management fees and expenses all may be associated with exchange-traded fund investments.  Please read the prospectus before investing.  The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Exchange-traded funds are not guaranteed, their values change frequently and past performance may not be repeated.

Certain statements contained in this document constitute forward-looking information within the meaning of Canadian securities laws. Forward-looking information may relate to matters disclosed in this document and to other matters identified in public filings relating to the Fund, to the future outlook of the Fund and anticipated events or results and may include statements regarding the future financial performance of the Fund. In some cases, forward-looking information can be identified by terms such as "may", "will", "should", "expect", "plan", "anticipate", "believe", "intend", "estimate", "predict", "potential", "continue" or other similar expressions concerning matters that are not historical facts. Actual results may vary from such forward-looking information. Investors should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and we assume no obligation to update or revise them to reflect new events or circumstances.

 



These press releases may also interest you

at 16:05
Data I/O Corporation , the leading global provider of advanced security and data deployment solutions for microcontrollers, security ICs and memory devices, today announced financial results for the first quarter ended March 31, 2024. First Quarter...

at 16:05
SkyWest, Inc. ("SkyWest") today reported financial and operating results for Q1 2024, including net income of $60 million, or $1.45 per diluted share, compared to net loss of $22 million, or $0.45 loss per share, for Q1 2023. Commenting on the...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first...

at 16:05
Bruker Corporation today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current...

at 16:05
Gilead Sciences, Inc. announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, Oncology and...



News published on and distributed by: